New Publications From the Smith Breast Center
October - December 2007
Lopez-Tarruella, S., and Schiff, R. The dynamics of estrogen receptor status in breast cancer: Reshaping the paradigm. Clin. Cancer Res. Dec. 1;13(23): 6921-5, 2007. [PDF]
Redell MS, Tsimelzon A, Hilsenbeck SG, Tweardy DJ (2007). Conditional overexpression of Stat3a in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern . J Leukocyte Biol 82:975-985. [PDF]
July - September 2007
Sampath L, Kwon S, Ke Shi, Wang W, Schiff R, Mawad M, Sevick-Muraca E: Dual-labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer. J Nucl Med. 2007 48:1501-1510. [PDF]
Lee S, Medina D, Tsimelzon A, Mohsin SK, Mao S, Wu Y, Allred DC (2007). Alterations of gene expresson in the development of early hyperplastic precursors of breast cancer. Am J Pathol 171(1):252-262. [PDF]
April - June 2007
Arpino, G., Gutierrez, C., Weiss, H., Rimawi, M., Massarweh, S., Bharwani, L., De Placido, D., Osborne, C.K., Schiff, R.. Eradication of ER-positive/HER2 overexpressing breast cancer xenografts with the combination of ER targeted therapy and complete blockade of the HER signaling pathway. JNCI 99(9):694-705, 2007. [PDF]
Friedman, L.C., Romero, C., Elledge, R., Chang, J., Kalidas, M., Dulay, M.F., Lynch, G.R., Osborne, C.K. Attribution of Blame, Self-forgiving Attitude and Psychological Adjustment in Women with Breast Cancer. J Behav Med 30(4):351-357, 2007. [PDF]
Chang, J.C., Makris, A., Gutierrez, C., Hilsenbeck, S.G., Hackett, J.R., Jeong, J., Liu, M-L., Baker, J., Clark-Langone, K., Baehner, F.L., Sexton, K., Mohsin, S., Gray, T., Alvarez, L., Chamnenss, G.C., Osborne, C.K., Shak, S. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Res Treat, 108(2):233-240. [PDF]
Pandya, K.J., Hu, P., Osborne, C.K., Falkson, G., Tormey, D.C.; Eastern Cooperative Oncology Group. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185). Am J Clin Oncol. 30(2):113-125, 2007. [PDF]
Massarweh S, Schiff R. Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities. Clin. Cancer Res. 2007 Apr 1;13(7):1950-4. [PDF]
Arpino G, Gutierrez C, Weiss H, Rimawi, M, Massarweh S, Bharwani L, De Placido S, Osborne CK, Schiff R. Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy. J Natl Cancer Inst. 2007 May2;99(9):694-705. [PDF]
Herynk, M.H., Parra, I., Cui, Y., Beyer, A., Wu, M-F, Hilsenbeck, S.G., and Fuqua, S.A.W.: Association between the estrogen receptor a A908G mutation and outcomes in invasive breast cancer. Clinical Can Res, 13: 2007, 3225-3243. [PDF]
Du & Li, RCAS-TVA in the mammary gland—an in vivo oncogene screen and a high fidelity model for breast transformation? Cell Cycle. 2007 [PDF]
January - March 2007
Linden, H.M., Haskell, C.M., Green, S.J., Osborne, C.K., Sledge, Jr., G.W., Shapiro, C.L., Ingle, J.N., Lew, D., Hutchins, L.F., Livingston, R.B. Sequenced Compared with Simultaneous Anthracycline and Cyclophosphamide in High-Risk Stage I and II Breast Cancer: Final Analysis from INT-0137 (S9313). JCO 25(6): 656-661. [PDF]
Kim H.J., Litzenburger B.C., Cui X., Delgado D.A., Grabiner B.C., Lin X., Lewis M.T., Gottardis M.M., Wong T.W., Attar R.M., Carboni J., Lee A.V. (2007) “Constitutively Active IGF-IR Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells, and is Accompanied by an Epithelial to Mesenchymal Transition Mediated by NF-kappaβ and Snail.” Mol. Cell. Biol. 2007 Feb 12 [PDF]
Moraes, R.C., Zhang, X., Harrington, N., Fung, J.Y., Wu, M.F., Hilsenbeck, S.G., Allred, D.C., and Lewis, M.T. (2007).,“Constitutive Activation of Smoothened (Smo) in Mammary Glands of Transgenic Mice Leads to Increased Proliferation, Altered Differentiation, and Ductal Dysplasia.” Development 134 (6): 1231-42. [PDF]